vs
Cooper Companies (The)（COO）与利氏兄弟拍卖行（RBA）财务数据对比。点击上方公司名可切换其他公司
利氏兄弟拍卖行的季度营收约是Cooper Companies (The)的1.1倍（$1.2B vs $1.1B），利氏兄弟拍卖行净利率更高（9.1% vs 7.9%，领先1.2%），利氏兄弟拍卖行同比增速更快（5.4% vs 4.6%），利氏兄弟拍卖行自由现金流更多（$186.5M vs $149.9M），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs 6.3%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
利氏兄弟拍卖行（股票代码RBA）是全球知名的工业资产拍卖服务商，注册地位于加拿大，属公开上市企业，总部设在美国伊利诺伊州韦斯特切斯特，普通股同时在多伦多证券交易所与纽约证券交易所挂牌交易。
COO vs RBA — 直观对比
营收规模更大
RBA
是对方的1.1倍
$1.1B
营收增速更快
RBA
高出0.8%
4.6%
净利率更高
RBA
高出1.2%
7.9%
自由现金流更多
RBA
多$36.6M
$149.9M
两年增速更快
COO
近两年复合增速
6.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.2B |
| 净利润 | $84.6M | $109.7M |
| 毛利率 | 61.1% | — |
| 营业利润率 | 13.2% | 14.7% |
| 净利率 | 7.9% | 9.1% |
| 营收同比 | 4.6% | 5.4% |
| 净利润同比 | -28.0% | -7.4% |
| 每股收益（稀释后） | $0.42 | $0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COORBA
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.0B | $1.2B | ||
| Q1 25 | $964.7M | $1.1B | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $1.0B | $981.8M | ||
| Q2 24 | $942.6M | $1.1B | ||
| Q1 24 | $931.6M | $1.1B |
净利润COORBA
| Q4 25 | $84.6M | $109.7M | ||
| Q3 25 | $98.3M | $95.5M | ||
| Q2 25 | $87.7M | $109.8M | ||
| Q1 25 | $104.3M | $113.4M | ||
| Q4 24 | $117.5M | $118.5M | ||
| Q3 24 | $104.7M | $76.1M | ||
| Q2 24 | $88.9M | $111.1M | ||
| Q1 24 | $81.2M | $107.4M |
毛利率COORBA
| Q4 25 | 61.1% | — | ||
| Q3 25 | 65.3% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 68.4% | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 66.1% | — | ||
| Q2 24 | 67.0% | — | ||
| Q1 24 | 67.0% | — |
营业利润率COORBA
| Q4 25 | 13.2% | 14.7% | ||
| Q3 25 | 16.6% | 14.5% | ||
| Q2 25 | 18.4% | 15.9% | ||
| Q1 25 | 18.9% | 17.1% | ||
| Q4 24 | 19.5% | 18.1% | ||
| Q3 24 | 19.2% | 15.6% | ||
| Q2 24 | 17.2% | 18.4% | ||
| Q1 24 | 16.4% | 18.7% |
净利率COORBA
| Q4 25 | 7.9% | 9.1% | ||
| Q3 25 | 9.3% | 8.7% | ||
| Q2 25 | 8.7% | 9.3% | ||
| Q1 25 | 10.8% | 10.2% | ||
| Q4 24 | 11.5% | 10.4% | ||
| Q3 24 | 10.4% | 7.8% | ||
| Q2 24 | 9.4% | 10.1% | ||
| Q1 24 | 8.7% | 10.1% |
每股收益（稀释后）COORBA
| Q4 25 | $0.42 | $0.53 | ||
| Q3 25 | $0.49 | $0.43 | ||
| Q2 25 | $0.44 | $0.53 | ||
| Q1 25 | $0.52 | $0.55 | ||
| Q4 24 | $0.59 | $0.58 | ||
| Q3 24 | $0.52 | $0.36 | ||
| Q2 24 | $0.44 | $0.54 | ||
| Q1 24 | $0.41 | $0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $531.5M |
| 总债务越低越好 | $2.5B | $2.3B |
| 股东权益账面价值 | $8.2B | $5.6B |
| 总资产 | $12.4B | $12.1B |
| 负债/权益比越低杠杆越低 | 0.30× | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资COORBA
| Q4 25 | $110.6M | $531.5M | ||
| Q3 25 | $124.9M | $674.7M | ||
| Q2 25 | $116.2M | $710.2M | ||
| Q1 25 | $100.9M | $578.1M | ||
| Q4 24 | $107.6M | $533.9M | ||
| Q3 24 | $109.7M | $650.7M | ||
| Q2 24 | $112.4M | $599.5M | ||
| Q1 24 | $135.2M | $462.8M |
总债务COORBA
| Q4 25 | $2.5B | $2.3B | ||
| Q3 25 | $2.4B | $2.6B | ||
| Q2 25 | $2.5B | $2.6B | ||
| Q1 25 | $2.5B | $2.6B | ||
| Q4 24 | $2.6B | $2.6B | ||
| Q3 24 | $2.6B | $2.7B | ||
| Q2 24 | $2.7B | $2.8B | ||
| Q1 24 | $2.7B | $2.9B |
股东权益COORBA
| Q4 25 | $8.2B | $5.6B | ||
| Q3 25 | $8.4B | $5.5B | ||
| Q2 25 | $8.3B | $5.5B | ||
| Q1 25 | $8.1B | $5.3B | ||
| Q4 24 | $8.1B | $5.2B | ||
| Q3 24 | $7.9B | $5.2B | ||
| Q2 24 | $7.8B | $5.2B | ||
| Q1 24 | $7.7B | $5.1B |
总资产COORBA
| Q4 25 | $12.4B | $12.1B | ||
| Q3 25 | $12.4B | $12.2B | ||
| Q2 25 | $12.4B | $12.2B | ||
| Q1 25 | $12.2B | $11.9B | ||
| Q4 24 | $12.3B | $11.8B | ||
| Q3 24 | $12.1B | $11.9B | ||
| Q2 24 | $12.0B | $12.1B | ||
| Q1 24 | $12.0B | $12.0B |
负债/权益比COORBA
| Q4 25 | 0.30× | 0.42× | ||
| Q3 25 | 0.29× | 0.47× | ||
| Q2 25 | 0.30× | 0.47× | ||
| Q1 25 | 0.31× | 0.50× | ||
| Q4 24 | 0.32× | 0.50× | ||
| Q3 24 | 0.33× | 0.52× | ||
| Q2 24 | 0.34× | 0.55× | ||
| Q1 24 | 0.35× | 0.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | $255.2M |
| 自由现金流经营现金流 - 资本支出 | $149.9M | $186.5M |
| 自由现金流率自由现金流/营收 | 14.1% | 15.5% |
| 资本支出强度资本支出/营收 | 9.2% | 5.7% |
| 现金转化率经营现金流/净利润 | 2.93× | 2.33× |
| 过去12个月自由现金流最近4个季度 | $433.7M | $719.2M |
8季度趋势，按日历期对齐
经营现金流COORBA
| Q4 25 | $247.9M | $255.2M | ||
| Q3 25 | $261.4M | $239.7M | ||
| Q2 25 | $96.2M | $326.5M | ||
| Q1 25 | $190.6M | $156.8M | ||
| Q4 24 | $268.1M | $184.5M | ||
| Q3 24 | $207.5M | $285.4M | ||
| Q2 24 | $111.0M | $337.3M | ||
| Q1 24 | $122.7M | $124.8M |
自由现金流COORBA
| Q4 25 | $149.9M | $186.5M | ||
| Q3 25 | $164.5M | $188.5M | ||
| Q2 25 | $18.1M | $241.7M | ||
| Q1 25 | $101.2M | $102.5M | ||
| Q4 24 | $128.1M | $127.9M | ||
| Q3 24 | $118.5M | $248.5M | ||
| Q2 24 | $36.9M | $308.6M | ||
| Q1 24 | $4.6M | $79.6M |
自由现金流率COORBA
| Q4 25 | 14.1% | 15.5% | ||
| Q3 25 | 15.5% | 17.3% | ||
| Q2 25 | 1.8% | 20.4% | ||
| Q1 25 | 10.5% | 9.2% | ||
| Q4 24 | 12.6% | 11.2% | ||
| Q3 24 | 11.8% | 25.3% | ||
| Q2 24 | 3.9% | 28.2% | ||
| Q1 24 | 0.5% | 7.5% |
资本支出强度COORBA
| Q4 25 | 9.2% | 5.7% | ||
| Q3 25 | 9.1% | 4.7% | ||
| Q2 25 | 7.8% | 7.2% | ||
| Q1 25 | 9.3% | 4.9% | ||
| Q4 24 | 13.7% | 5.0% | ||
| Q3 24 | 8.9% | 3.8% | ||
| Q2 24 | 7.9% | 2.6% | ||
| Q1 24 | 12.7% | 4.2% |
现金转化率COORBA
| Q4 25 | 2.93× | 2.33× | ||
| Q3 25 | 2.66× | 2.51× | ||
| Q2 25 | 1.10× | 2.97× | ||
| Q1 25 | 1.83× | 1.38× | ||
| Q4 24 | 2.28× | 1.56× | ||
| Q3 24 | 1.98× | 3.75× | ||
| Q2 24 | 1.25× | 3.04× | ||
| Q1 24 | 1.51× | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
RBA
| Buyer Revenue | $577.2M | 48% |
| Seller Revenue | $255.2M | 21% |
| CA | $199.0M | 17% |
| Other | $124.7M | 10% |
| AU | $47.3M | 4% |
